Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nyse  >  Rite Aid Corporation    RAD

Delayed Quote. Delayed  - 07/27 10:00:30 pm
6.97 USD   --.--%
07/25 RITE AID : Helps Students Prepare For Upcoming School Year With Uniq..
07/25 RITE AID : Drug store chain plans next location
07/23 BRIEF : Man steals drugs from Rite Aid pharmacy in Naples
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector news 

Rite Aid March Same-Store Sales Rose 3.6%

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/05/2012 | 03:02pm CEST

Rite Aid Corp.'s (>> Rite Aid Corporation) same-store sales rose 3.6% in March, continuing a streak of monthly growth for the drugstore chain.

The No. 3 U.S. drugstore chain behind Walgreen Co. (WAG) and CVS Caremark Corp. (>> CVS Caremark Corporation) reported same-store sales growth in all but one month during 2011; March 2011 had a 0.1% drop. Last month Rite Aid reported its fourth-quarter same-store sales rose 3%, its best showing in five years.

Analysts have been expecting Rite Aid and CVS to gain market share as a result of Walgreen's exiting pharmacy benefits manager Express Scripts Holding Co.'s (ESRX) network late last year. The move was expected to result in some of Walgreen's customers going to competitors such as Rite Aid to fill prescriptions.

During March, same-store sales were up 4.6% in the front of the store.

Pharmacy same-store sales increased 3.2%, despite a negative impact of 2.4 percentage points from generic drug introductions. Same-store prescription counts grew 2.6%.

Total March drugstore sales rose 3.1% to $1.99 billion. Prescription sales accounted for 69.2% of drugstore sales.

Rite-Aid, which has about 4,659 stores, has posted losses since its 2007 acquisition of the Brooks and Eckerd chain stores that saddled it with debt just before consumers slashed spending.

The company in December reported that its fiscal third-quarter loss narrowed on higher same-store sales as the drugstore chain's wellness and loyalty and flu-immunization programs lifted pharmacy-department sales.

Shares were up 2.3% at $1.75 in recent premarket trading.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; Tess.Stynes@dowjones.com

Stocks mentioned in the article : Rite Aid Corporation, CVS Caremark Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on RITE AID CORPORATION
07/25 RITE AID : Helps Students Prepare For Upcoming School Year With Unique and Class..
07/25 RITE AID : Drug store chain plans next location
07/23 BRIEF : Man steals drugs from Rite Aid pharmacy in Naples
07/23 RITE AID : Men arrested in Ambridge credit card scam
07/22 RITE AID : Branding deal doubles free ATM access for NY FI's cardholders
07/21 RITE AID : ZBA Concord Market gets OK
07/21 RITE AID : Patch of grass almost mows down Rite-Aid's planned new store in Strou..
07/20 RITE AID : Foundation Joins RACHAEL RAY Show in Supporting Downtown Boxing Gym Y..
07/20 DENNY : An undercover teen walks into a bar ...
07/17 RITE AID : Sing In The Shower Over Bath, Body Product Deals
More news
Sector news : Retail - Drugs without Grocery
07/27DJMCKESSON : Profit Declines
07/25DJEXPRESS SCRIPTS : Narrows Annual Guidance
07/25DJEXPRESS SCRIPTS : Narrows Annual Guidance
07/21 MCKESSON : Theranos hires executives in regulatory, compliance push
07/21DJTheranos Hires Compliance, Regulatory Executives
More sector news : Retail - Drugs without Grocery
News from SeekingAlpha
07/20 Rite Aid slips on concerns over Walgreens deal
07/19 Warren Buffett Finds A Gem
07/18 AT&T Heads South Of The Border
07/18 From A Penny To A Billion Dollars
07/16 Can Walgreens Survive Brexit?
Advertisement
Financials ($)
Sales 2017 32 966 M
EBIT 2017 709 M
Net income 2017 151 M
Debt 2017 6 717 M
Yield 2017 -
P/E ratio 2017 43,24
P/E ratio 2018 27,96
EV / Sales 2017 0,43x
EV / Sales 2018 0,40x
Capitalization 7 311 M
More Financials
Chart RITE AID CORPORATION
Duration : Period :
Rite Aid Corporation Technical Analysis Chart | RAD | US7677541044 | 4-Traders
Full-screen chart
Technical analysis trends RITE AID CORPORATION
Short TermMid-TermLong Term
TrendsBearishBearishNeutral
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 9
Average target price 8,86 $
Spread / Average Target 27%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
John T. Standley Chairman & Chief Executive Officer
Kenneth A. Martindale President & Chief Operating Officer
Darren W. Karst SEVP, Chief Financial & Administrative Officer
Steve Rempel Chief Information Officer & Senior Vice President
Joseph B. Anderson Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
RITE AID CORPORATION-11.10%7 311
RAIA DROGASIL SA81.27%6 294
AIN HOLDINGS INC28.05%2 164
ORIOLA KD OYJ-2.31%840
AUSTRALIAN PHARMACEUTI..-3.63%699
ADCOCK INGRAM HOLDINGS..-4.71%577
More Results